Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. MJS Medicals
WARNING LETTER
•MJS Medicals

MJS Medicals – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to MJS Medicals on November 3, 2025, after reviewing their website, www.mjsmedicals.com. The letter identifies significant violations related to the introduction of unapproved new drugs and misbranded drugs into U.S. interstate commerce. Specifically, MJS Medicals is offering injectable botulinum toxin drug products, such as "Innotox 100ui" and "Innotox 100u." These products are considered unapproved new drugs under sections 301(d) and 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because they lack the necessary FDA approval to ensure safety and effectiveness. Furthermore, the products are deemed misbranded under sections 301(a) and 502(f)(1) of the FD&C Act. As prescription drugs intended for conditions not amenable to self-diagnosis, their labeling fails to provide adequate directions for use by a layperson. The FDA emphasizes the inherent risks associated with unapproved and misbranded injectable drugs, including potential contamination and serious health complications. MJS Medicals is required to immediately cease selling these unapproved and misbranded drugs to U.S. consumers and to notify the FDA within 15 working days, detailing the specific steps taken to correct all identified violations and prevent their recurrence, along with supporting documentation. Failure to comply may lead to further legal action.

Company
MJS Medicals
Product type
Drugs
Office
Office of Drug Security, Integrity, and Response
Person
  • Sangeeta V. Chatterjee
View Company Profile

ID · 93fe2607-308f-4539-bd1e-cdb1c3e0b0e6

Violation Codes10
FD&C Act 301(a)FD&C Act 301(d)FD&C Act 503(b)FD&C Act 505(a)21.U.S.C. 331(a)21 U.S.C. 331(d)21 U.S.C. 353(b)21.U.S.C. 355(a)FD&C Act 201(g)21 U.S.C. 321(g)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MJS Medicals
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.